
October 2, 2024
RegMed Investors (RMi) Closing Bell: cell and gene therapy sector investors need to hold
October 2, 2024
RegMed Investors’ (RMi) pre-open: headwinds, it ain’t over as Q4 begins
October 1, 2024
RegMed Investors (RMi) Closing Bell: a barrage of negative sentiment hits cell and gene therapy sector
September 30, 2024
RegMed Investors (RMi) Closing Bell: ducking the shrapnel of exploding cell and gene therapy sector valuations
September 30, 2024
RegMed Investors’ (RMi) pre-open: wake up, will Q3, September end today with a downbeat session
September 27, 2024
RegMed Investors (RMi) Closing Bell: the week that was as September and Q3 ends Monday
September 27, 2024
RegMed Investors’ (RMi) pre-open: Don’t squat with your spurs on
September 26, 2024
RegMed Investors (RMi) Closing Bell: sectors back in a positive close as econs follow expectation
September 26, 2024
RegMed Investors’ (RMi) pre-open: more economic news weekly jobless claims and Q2 GDP
September 25, 2024
RegMed Investors (RMi) Closing Bell: sector rumpled and tumbled
35 companies, 1 interpreter!
Insight, foresight and recommendation
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors